ArticleArchives of virology2025
Transcriptomic analysis reveals Rnd1 to be a key player in antiviral immunity against Akabane virus via the TNF-α pathway.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Akabane virus (AKAV), the etiological agent of Akabane disease, is known to induce congenital malformations and neuropathologies in the fetuses of pregnant cattle and sheep. To analyze the changes in gene expression patterns that occur in AKAV-infected cells, two types of primary bovine cells - primary bovine testicular Sertoli cells (BTSCs) and primary bovine joint synovial cells (BJSCs) - were selected. These cells were confirmed to be infected by AKAV strain TJ2016. Subsequently, RNA-sequencing technology was employed to analyze the transcriptomic profiles of AKAV-infected BTSCs and BJSCs, as well as Madin-Darby ovine kidney (MDOK) cells. The AKAV-infected cells exhibited activation of antiviral signaling pathways. Notably, there was upregulation of the expression levels of interferon-stimulated genes, as well as genes related to inflammation and cytokines. IL-1β, TNF-α, CXCL8, CCL2, and Rnd1 were found to be significantly upregulated in AKAV-infected cells. Moreover, Rnd1 was found to inhibit the replication of AKAV. Because TNF-α plays an important role in the induction of Rnd1, this provides additional evidence for the regulation and function of Rnd1.
Indexed as
Identifiers
41313489What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.